Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	[1]
Statement of Comprehensive Income [Abstract]
Net income	$ 146,860	$ 75,465	[2]
Other comprehensive income:
Foreign currency translation adjustments	0	8
Total other comprehensive income	146,860	75,473
Comprehensive income attributable to non-controlling interests	79,998	52,369
Total comprehensive income attributable to Maravai LifeSciences Holdings, Inc.	$ 66,862	$ 23,104

[1] As adjusted to reflect the impact of the adoption of ASC 842. See Note 1 to the condensed consolidated financial statements for a summary of the adjustments.

[2] As adjusted to reflect the impact of the adoption of Accounting Standards Codification 842 (“ASC 842”). See Note 1 to the condensed consolidated financial statements for a summary of the adjustments.